debt_leverage_profile
Near-zero debt; Cronos holds ~$850M+ cash/equivalents with minimal long-term debt, making a 20bps rate rise immaterial to interest expense
Inferred
Agent_Inference
interest_rate_sensitivity
Minimal sensitivity; higher rates marginally improve interest income on large cash reserves, net positive ~$1-2M per 20bps rise
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
Canadian cannabis cultivation regulatory constraints and Israeli cannabis import/export controls (Cronos Israel) are top two chokepoints
Inferred
Agent_Inference
international_expansion_readiness
Exposure to ILS (Israel), EUR (Germany/Europe), and CAD devaluation; ILS and EUR volatility pose modest FX translation risk on minority revenues
Inferred
Agent_Inference
geographic_footprint
Operates in Canada (primary), Israel, Germany, and Australia; ~80%+ revenue Canada-based, limiting but not eliminating sovereign FX devaluation exposure
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
No single vendor exceeds 30% of operational input; cannabis cultivation inputs are commoditized, though licensed grow-equipment suppliers create moderate dependency
Inferred
Agent_Inference
business_model_type_primary
Physical product manufacturer/distributor (cannabis); not cloud-dependent for core operations; a cloud termination causes IT disruption but not business collapse
Inferred
Agent_Inference
business_model_type_secondary
B2C and B2B cannabis product sales via retail and wholesale; cloud disruption manageable within 30-90 days through provider migration
Inferred
Agent_Inference
switching_cost_profile
Low API coupling risk; Cronos is a CPG-style cannabis company with minimal proprietary API dependencies in its core revenue model
Inferred
Agent_Inference
howey_test_risk_index
Fails Howey Test; cannabis product sales are straightforward commodity/CPG transactions, not investment contracts — negligible securities classification risk
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Moderate GDPR/CCPA exposure via consumer marketing data in EU/California; cannabis sector data handling adds regulatory sensitivity but company scale limits systemic risk
Inferred
Agent_Inference
antitrust_exposure_flag
Low antitrust risk; Cronos holds small market share in fragmented Canadian and global cannabis markets with no dominant pricing power
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
Predominantly transactional (~90%+); cannabis product sales are largely spot/wholesale transactions with no meaningful subscription or multi-year contract revenue
Inferred
Agent_Inference
monetization_vector
Product sales (dried flower, extracts, vapes, topicals) through wholesale and retail channels; no recurring SaaS or licensing monetization
Inferred
Agent_Inference
pricing_architecture
Weak pricing architecture; commodity-like cannabis market with intense price compression in Canada; limited ability to hold premium pricing under stress
Inferred
Agent_Inference
pricing_power_rating
2/5 — Canadian cannabis oversupply and commoditization severely constrain pricing power; premium brand (PEACE NATURALS, Spinach) provides marginal buffer only
Inferred
Agent_Inference
target_gross_margin_bracket
42.8% Gross Margin (Strong (40-60%))
High
SEC-XBRL
churn_vulnerability_index
Moderate free-rider leakage via illicit market competition; consumers substitute licensed product with lower-cost illegal cannabis, a structural Canadian market problem
Inferred
Agent_Inference
headcount_cost_structure
Headcount-linear to sublinear; manufacturing/cultivation scales with volume but administrative overhead grows slower; doubling revenue requires ~60-70% headcount growth
Inferred
Agent_Inference
marginal_cost_of_growth
Moderate marginal cost; expansion requires cultivation capacity capex and regulatory licensing investment but manufacturing automation provides some sublinear scaling
Inferred
Agent_Inference
franchise_compliance_risk
Not applicable; Cronos does not operate a franchise model
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, CAC economics remain challenged; cannabis advertising restrictions limit digital CAC efficiency, relying on distributor/retailer relationships and brand shelf placement
Inferred
Agent_Inference
network_effect_present
No meaningful network effects; cannabis is a physical consumer product with no user-growth-driven value compounding
Inferred
Agent_Inference
asset_efficiency_ratio
-1.4% Return on Assets (Negative equity)
High
SEC-XBRL
recession_resistance_tier
Tier 2 (moderate resilience); cannabis shows some counter-cyclical demand traits but premium SKUs face trading-down risk; illicit market gains share in downturns
Inferred
Agent_Inference
customer_segment_primary
Adult recreational cannabis consumers (Canada primary); no single retail customer represents dominant concentration due to provincial board distribution model
Inferred
Agent_Inference
customer_segment_secondary
Medical cannabis patients and international wholesale buyers (Israel, Germany); government/provincial wholesale boards represent concentrated purchasing intermediaries
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
17.5% CapEx / Revenue (High-CapEx Infrastructure)
High
SEC-XBRL
sec_cik
0001656472
High
SEC-EDGAR
ticker
CRON
High
SEC-EDGAR